The next-generation KRAS G12C inhibitor MK-1084 showed promising efficacy and safety as a single agent and in combinations ...

Paweł’s decision reflects a growing challenge in Poland’s labour market. An ageing population and historically low ...

Immutep’s efti with radiotherapy and pembrolizumab meets primary endpoint in phase II trials for soft tissue sarcoma ...

Novel combination with efti has met the trial's primary endpoint of tumour hyalinization/fibrosis in the neoadjuvant setting for patients with resectable soft tissue sarcomaDetailed results are planne ...

9). Marie Curie (1867–1934) Born Maria Sklodowska, she was not allowed to go to Warsaw’s male-only university in the late 1800s, so she studied math and science on her own, working as a ...

I am therefore satisfied with these announcements," said Maria Leptin ... she wants to "strengthen" the highly appreciated Marie Sklodowska-Curie fellowships, which support young researchers.

Efti combination demonstrates significant tumor response in sarcoma trial, exceeding expectations without chemotherapy.

CEO Marc Voigt delivers an update on the company’s recent clinical milestones, highlighting significant progress across multiple cancer indications. The focus of the presentation is the company’s ...

chairman of the Ethics Committee of the Institute Curie and great-grandson of Maria Skłodowska-Curie. The Polish Ambassador, together with the school's management, opened an exhibition about ...

The Marie Sklodowska-Curie Fellowship Programme (MSCFP) aims to help increase the number of women in the nuclear field, supporting an inclusive workforce of both men and women who contribute to and ...

DEFENDOR SPECIAL: Effect of primary prophylaxis with empegfilgrastim on pCR rate after neoadjuvant TCHP in early HER2+ breast cancer patients—Matching-adjusted indirect comparison (MAIC). This is an ...